Meeting with Patricia Reilly (Cabinet of President Ursula von der Leyen)

23 Sept 2025 · to follow

Response to Commission Communication on a EU Cardiovascular Health Plan

16 Sept 2025

Meeting with Marion Walsmann (Member of the European Parliament, Rapporteur for opinion)

4 Sept 2025 · Critical Medicines Act

Meeting with Oliver Schenk (Member of the European Parliament)

9 Jul 2025 · Frauengesundheit in der EU

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

4 Jul 2025

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

10 Jun 2025

Meeting with Andreas Glück (Member of the European Parliament, Shadow rapporteur for opinion)

22 May 2025 · Critical Medicines

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EU) 2023/1115 of the European Parliament and of the Council as regards the list of relevant commodities and relevant products

13 May 2025

Response to Communication on the EU Stockpiling Strategy

8 May 2025

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

17 Apr 2025

Response to Evaluation of Directive 2014/23/EU on the award of concessions contracts, Directive 2014/24/EU on public procurement, and Directive 2014/25/EU on procurement by entities operating in the water, energy, transport and postal services sectors

7 Mar 2025

Response to Critical Medicines Act

27 Feb 2025

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down good manufacturing practice for veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council

19 Feb 2025

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down good manufacturing practice for active substances used as starting materials in veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council

19 Feb 2025

Meeting with Tiemo Wölken (Member of the European Parliament)

5 Feb 2025 · Women's Health

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... amending Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance of pharmacovigilance activities provided for in Regulation (EC) No 726/2004 of the European Parliament and of the Council and Directive 2001/83/EC of the European Parliament and of the Council

15 Jan 2025

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medicinal products for human use at Union level

24 Oct 2024

Response to The new ERA four years on: Achievements, lessons learned and challenges for the future

30 Sept 2024

Meeting with Andreas Glück (Member of the European Parliament)

23 Sept 2024 · Health

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devices

23 Jul 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

26 Jun 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

2 Apr 2024

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use

26 Feb 2024

Meeting with Andreas Glück (Member of the European Parliament)

13 Feb 2024 · Event on Health Claims

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

20 Dec 2023 · Revision of Pharmaceutical Package (staff level)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

20 Dec 2023 · Directive on Medicinal products for human use

Response to Administrative burden

27 Nov 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

1 Nov 2023

Response to Commission Delegated Regulation supplementing Directive 2001/83/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council on the examination of variations to the terms of marketing authorisations for medicinal products for human use and amending Commission Regulation (EC) No 1234/2008 of 24 November 2008

22 Sept 2023

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and Verband der Chemischen Industrie e.V.

13 Sept 2023 · SPC and Compulsory Licensing

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and 9 other interest representatives

7 Sept 2023 · Revision of the Pharmaceutical Legislation (staff level)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and MEDICINES FOR EUROPE

6 Sept 2023 · Directive on Medicinal products for human use

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and AbbVie

28 Jun 2023 · Revision of Pharmaceutical Legislation (staff level)

Meeting with Andreas Glück (Member of the European Parliament)

13 Jun 2023 · Health Claims

Meeting with Norbert Lins (Member of the European Parliament, Committee chair)

31 May 2023 · "Health Claims" (gesundheitsbezogene Werbung)

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on packaging and packaging waste, amending Regulation (EU) 2019/1020 and Directive (EU) 2019/904, and repealing Directive 94/62/EC

6 Apr 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space

28 Jul 2022

Response to Enhancing the coherence and effectiveness of compulsory licensing of patents in the EU, especially in crisis situations, including for export purposes to third countries

29 Apr 2022

Meeting with Axel Voss (Member of the European Parliament, Shadow rapporteur)

7 Sept 2021 · Corporate Sustainability Due Diligence

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

22 Dec 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

6 Jul 2020

Response to COMMISSION REGULATION (EU) …/… amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards botanical species containing hydroxyanthracene derivatives

9 Apr 2020

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

10 Feb 2017 · Pharmaceuticals, Medicinal Products, HTA

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

12 Oct 2016 · EU regulatory framework for pharmaceuticals, access to medicines, HTA

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

4 Feb 2015 · Access to innovative medicine